Business Wire

Reprieve Cardiovascular Completes Enrollment in Randomized Pilot Trial Evaluating First-of-its-Kind Personalized Fluid Management System for Acute Decompensated Heart Failure

MILFORD, Mass.--(BUSINESS WIRE)--Reprieve Cardiovascular, Inc., a development-stage company pioneering an intelligent automated diuretic and fluid management approach for acute decompensated heart ...
Business Wire

Reprieve Cardiovascular Emerges from Stealth Mode after $42 Million Series A Financing to Bring Intelligent Fluid Management to Heart Failure Patients

MILFORD, Mass.--(BUSINESS WIRE)--Reprieve Cardiovascular, Inc., a development stage company focused on pioneering an intelligent automated diuretic and fluid management approach for acute ...
MD&M East

New Cardiovascular Company Emerges from Stealth Mode

Reprieve Cardiovascular recently emerged from stealth mode after raising $42 million in series A financing. The Milford, MA-based company is developing a system intended to personalize decongestion ...
Healio

New data question benefit of fluid restriction in chronic heart failure

Please provide your email address to receive an email when new articles are posted on . Fluid restriction has long been recommended for patients with HF. Restricted vs. liberal fluid restriction did ...